Cargando…

Circulating Matrix Metalloproteinase-9 Is Associated with Cardiovascular Risk Factors in a Middle-Aged Normal Population

BACKGROUND: Elevated levels of circulating matrix metalloproteinase-9 (MMP-9) have been demonstrated in patients with established coronary artery disease (CAD). The aim of this study was to analyse levels of MMP-9 in a population free from symptomatic CAD and investigate their associations with card...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garvin, Peter, Nilsson, Lennart, Carstensen, John, Jonasson, Lena, Kristenson, Margareta
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2258002/ https://www.ncbi.nlm.nih.gov/pubmed/18335048 http://dx.doi.org/10.1371/journal.pone.0001774

Ejemplares similares

Plasma Matrix Metalloproteinase-9 Levels Predict First-Time Coronary Heart Disease: An 8-Year Follow-Up of a Community-Based Middle Aged Population
por: Garvin, Peter, et al.
Publicado: (2015)

Psychological Resources Are Independently Associated with Markers of Inflammation in a Middle-Aged Community Sample
por: Marteinsdottir, Ina, et al.
Publicado: (2016)

Mindfulness-Based Stress Reduction for Coronary Artery Disease Patients: Potential Improvements in Mastery and Depressive Symptoms
por: Lundgren, Oskar, et al.
Publicado: (2021)

Psychological Resources are Associated with Reduced Incidence of Coronary Heart Disease. An 8-Year Follow-up of a Community-Based Swedish Sample
por: Lundgren, Oskar, et al.
Publicado: (2014)

Inverted items and validity: A psychobiological evaluation of two measures of psychological resources and one depression scale
por: Lundgren, Oskar, et al.
Publicado: (2018)

A journey through chaos and calmness: experiences of mindfulness training in patients with depressive symptoms after a recent coronary event - a qualitative diary content analysis
por: Lundgren, Oskar, et al.
Publicado: (2018)

Psychological factors related to physical, social, and mental dimensions of the SF-36: a population-based study of middle-aged women and men
por: Nilsson, Evalill, et al.
Publicado: (2010)

SF-36 predicts 13-year CHD incidence in a middle-aged Swedish general population
por: Nilsson, Evalill, et al.
Publicado: (2019)

The joint subclinical elevation of CRP and IL-6 is associated with lower health-related quality of life in comparison with no elevation or elevation of only one of the biomarkers
por: Garvin, Peter, et al.
Publicado: (2015)

Choice of measure matters: A study of the relationship between socioeconomic status and psychosocial resources in a middle-aged normal population
por: Festin, Karin, et al.
Publicado: (2017)

Measuring psychosocial factors in health surveys using fewer items
por: Nilsson, Evalill, et al.
Publicado: (2020)

Pronounced Diurnal Pattern of Salivary C-Reactive Protein (CRP) With Modest Associations to Circulating CRP Levels
por: Wetterö, Jonas, et al.
Publicado: (2021)

Smoking Induces the Circulating Levels of Matrix Metalloproteinase-9 and Its Association with Cardiovascular Risk in Young Smokers
por: NATH, Dinesh, et al.
Publicado: (2022)

Impact of Matrix Metalloproteinase-9 during Periodontitis and Cardiovascular Diseases
por: Isola, Gaetano, et al.
Publicado: (2021)

Associations of Psychosocial Factors with Multiple Health Behaviors: A Population-Based Study of Middle-Aged Men and Women
por: Thomas, Kristin, et al.
Publicado: (2020)

Salivary and plasma levels of matrix metalloproteinase-9 and myeloperoxidase at rest and after acute physical exercise in patients with coronary artery disease
por: Mahmood, Zeid, et al.
Publicado: (2019)

Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013)

Plasma type I collagen α1 chain in relation to coronary artery disease: findings from a prospective population-based cohort and an acute myocardial infarction prospective cohort in Sweden
por: Hammaréus, Filip, et al.
Publicado: (2023)

Elevated concentrations of serum matrix metalloproteinase-2 and -9 and their associations with circulating markers of cardiovascular diseases in chronic arsenic-exposed individuals
por: Islam, Md Shofikul, et al.
Publicado: (2015)

Circulating Matrix Metalloproteinase-2 and -9 Enzyme Activities in the Children with Ventricular Septal Defect
por: Cheng, Kun-Shan, et al.
Publicado: (2013)

Significance of Circulating and Crevicular Matrix Metalloproteinase-9 in Rheumatoid Arthritis-Chronic Periodontitis Association
por: Silosi, Isabela, et al.
Publicado: (2015)

Involvement of Matrix Metalloproteinase 9 in Vertebral Arterial Dissection With Posterior Circulation Ischemic Stroke
por: Chen, Chun‐Yu, et al.
Publicado: (2020)

Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration
por: Zeng, Renpan, et al.
Publicado: (2013)

Aging is associated with increased activities of matrix metalloproteinase-2 and -9 in tenocytes
por: Yu, Tung-Yang, et al.
Publicado: (2013)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Matrix Metalloproteinase-9 (MMP9)—A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders
por: Rybakowski, Janusz K.
Publicado: (2009)

Important role of matrix metalloproteinase 9 in epileptogenesis
por: Wilczynski, Grzegorz M., et al.
Publicado: (2008)

Expression of Matrix Metalloproteinase-9 in Gastric Cancer
por: R, Prathipaa, et al.
Publicado: (2021)

Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
por: Wei, Ting, et al.
Publicado: (2016)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023)

Expression and Significance of Matrix Metalloproteinase-2 and Matrix Metalloproteinas-9 in Endometriosis
por: Barbe, Adrian Mykhailovych, et al.
Publicado: (2020)

Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke
por: Manso, Helena, et al.
Publicado: (2010)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tatkrf1j9v07kmnublic9j9hdj